Gastric Inhibitory Polypeptide: Clinical Trials

1 trial of Gastric Inhibitory Polypeptide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Gastric Inhibitory Polypeptide: new trials by email Literature Review of Gastric Inhibitory Polypeptide trials Research Report on Gastric Inhibitory Polypeptide

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GIP: Glucose-dependent Insulinotropic Peptide
GIP, Modified GIP, Normal Saline - Type 2 Diabetes
Phase 1CompletedNational Institute on Aging (NIA)412003-02-012013-11-28

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Insulin Resistance (1)

Sponsors

National Institute on Aging (NIA) (1)

Countries

United States (1)

Top investigators

Josephine Egan, MD (1)

Results publications

PMID 24712564